Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
NCT00976768
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Cancer
Interventions
DRUG:
oxaliplatin, 5-fluorouracil
Sponsor
Asan Medical Center